HIGHLIGHT
Zifam Linglip

Zifam Linglip

linagliptin

Manufacturer:

Zifam Pinnacle

Distributor:

Pinnacle House
Concise Prescribing Info
Contents
Linagliptin
Indications/Uses
Adjunct to diet & exercise to improve glycaemic control in patients w/ type 2 DM as monotherapy or combination therapy w/ metformin, sulphonylurea + metformin or insulin w/ or w/o metformin.
Dosage/Direction for Use
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to any dipeptidylpeptidase-4 (DPP-4) inhibitor.
Special Precautions
Not for use in patients w/ type 2 diabetes or the treatment of diabetic ketoacidosis. Increased incidence of hypoglycaemia w/ sulphonylurea &/or insulin; may consider dose reduction of sulphonylurea or insulin. Discontinue if pancreatitis is suspected. Elderly (>80 yr).
Adverse Reactions
MIMS Class
ATC Classification
A10BH05 - linagliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Zifam Linglip FC tab 5 mg
Packing/Price
10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in